Chembio Diagnostics to Report Third Quarter 2020 Financial Results on November 5, 2020
October 23 2020 - 8:00AM
Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care
diagnostics company focused on infectious diseases, announced today
that it will release financial results for the third quarter 2020
after the close of trading on Thursday, November 5, 2020.
The company’s management team will host a
corresponding conference call beginning at 4:30 p.m. Eastern Time.
Investors interested in listening to the conference call may do so
by dialing 844-602-0380 from the US or 862-298-0970 from outside
the US or by accessing
www.chembio.com/investors/calendar-of-events/. A replay of the call
will be available by dialing 877-481-4010 from the US or
919-882-2331 from outside the US (using passcode 38202) or by
accessing www.chembio.com/investors/calendar-of-events/.
About Chembio
DiagnosticsChembio is a leading point-of-care diagnostics
company focused on detecting and diagnosing infectious diseases,
including COVID-19, sexually transmitted disease, and fever and
tropical disease. Coupled with Chembio’s extensive scientific
expertise, its novel DPP technology offers broad market
applications beyond infectious disease. Chembio’s products are sold
globally, directly and through distributors, to hospitals and
clinics, physician offices, clinical laboratories, public health
organizations, government agencies, and consumers. Learn more at
www.chembio.com.
DPP is Chembio’s registered trademark. For
convenience, this trademark appears in this release without ®
symbols, but that practice does not mean that Chembio will not
assert, to the fullest extent under applicable law, its rights to
the trademark.
Investor contact: |
|
Philip TaylorGilmartin Group(415) 937-5406investor@chembio.com |
Chembio Diagnostics (NASDAQ:CEMI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Chembio Diagnostics (NASDAQ:CEMI)
Historical Stock Chart
From Apr 2023 to Apr 2024